AURX NUO THERAPEUTIC
-
NUO THERAPEUTIC Reported Earnings
Friday, August 14, 2026 · 12:00 AM ET
NUO THERAPEUTIC (AURX) reported a loss of $0.01 per share on revenue of $1.77 million for the . .
Nuo Therapeutics Inc. is a commercial stage medical device company pioneering edge biodynamic therapies by focusing on emerging opportunities in the evolving healthcare landscape. Nuo Therapeutics Inc. is based in HOUSTON.
Reported Earnings
($0.01)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth—
Reported Revenue
$1.77M
Revenue Estimate
—
Revenue Surprise
Revenue Growth—